Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NTRK 1,2,3 Rearrangements in Patients With Solid Tumors

NCT06780384 is registered in ClinicalTrials.gov with Federico Cappuzzo as lead sponsor.

NCT NCT06780384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors
Lead sponsor
Federico Cappuzzo
Phase
Observational
Overall status
Active, not recruiting
Start date
February 5, 2020
Completion date
August 31, 2025
Enrollment
5,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ntrk1/2/3 fusion gene detection